SCHEMBL23382996

SCHEMBL23382996

CC(C)C1(OC(=O)c2ccc(C(=O)OCC(F)(F)C(=O)O)cc2)CCCCC1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 1/20 0.35
▸ HIF1A Q16665 1/20 0.35
▸ MAPT P10636 1/20 0.34
▸ KMT2A Q03164 3/20 0.34
▸ CYP2D6 P10635 2/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ ADRB2 P07550 4/20 0.33
▸ ADRB1 P08588 4/20 0.33
▸ ADRB3 P13945 4/20 0.33
▸ TSHR P16473 1/20 0.33
▸ ALDH1A1 P00352 2/20 0.32
▸ ADORA3 P0DMS8 1/20 0.32
▸ CHRM2 P08172 1/20 0.32
▸ CHRM4 P08173 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23382994 0.99 MAPK1 (0.36) MAPK1HIF1AMAPTKMT2ACYP2D6
SCHEMBL23382699 0.88 ADORA3 (0.36) MAPK1HIF1AMAPTKMT2ACYP2D6
SCHEMBL23382698 0.87 ALDH1A1 (0.36) MAPK1HIF1AMAPTKMT2ACYP2D6
SCHEMBL23382995 0.85 CYP19A1 (0.39) MAPK1HIF1AKMT2ACYP2D6MEN1
SCHEMBL23382487 0.84 MAPK1 (0.40) MAPK1HIF1AKMT2ACYP2D6MEN1
SCHEMBL23382992 0.82 SMN1; SMN2 (0.39) MAPK1HIF1AKMT2ACYP2D6MEN1
SCHEMBL23382999 0.81 NPSR1 (0.40) MAPK1HIF1AMAPTKMT2ACYP2D6
SCHEMBL23382702 0.78 ADORA3 (0.38) MAPK1HIF1AMAPTKMT2ACYP2D6
SCHEMBL23382819 0.78 PDCD1 (0.33) KMT2ACYP2D6MEN1CYP1A2SCN1A
SCHEMBL23382696 0.77 MAPK1 (0.38) MAPK1HIF1AKMT2ACYP2D6MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11762287-B2 Onium salt compound, chemically amplified resist composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-09-19 — — US disclosed
US-11762287-B2 Onium salt compound, chemically amplified resist composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-09-19 — — US disclosed
US-20210149301-A1 ONIUM SALT COMPOUND, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2021-05-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11762287-B2 Onium salt compound, chemically amplified resist composition and patterning process IDUA, SLC6A5, SLC6A9 MAPK1 229/4885HIF1A 4225/4885MAPT 1694/4885
US-20210149301-A1 ONIUM SALT COMPOUND, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS IDUA, SLC6A5, SLC6A9 MAPK1 229/4885HIF1A 4225/4885MAPT 1694/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback